Article Versions Notes

Molla MHR, Aljahdali MO, Sumon MAA, Asseri AH, Altayb HN, Islam MS, Alsaiari AA, Opo FADM, Jahan N, Ahammad F, et al. Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals. 2023; 16(1):120. https://doi.org/10.3390/ph16010120

Molla, Mohammad Habibur Rahman, Mohammed Othman Aljahdali, Md Afsar Ahmed Sumon, Amer H. Asseri, Hisham N. Altayb, Md. Shafiqul Islam, Ahad Amer Alsaiari, F. A. Dain Md Opo, Nushrat Jahan, Foysal Ahammad, and et al. 2023. "Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1" Pharmaceuticals 16, no. 1: 120. https://doi.org/10.3390/ph16010120

Molla, M. H. R., Aljahdali, M. O., Sumon, M. A. A., Asseri, A. H., Altayb, H. N., Islam, M. S., Alsaiari, A. A., Opo, F. A. D. M., Jahan, N., Ahammad, F., & Mohammad, F. (2023). Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1. Pharmaceuticals, 16(1), 120. https://doi.org/10.3390/ph16010120